Compare Apatinib Plus Capecitabine Versus Capecitabine in Maintenance Therapy for Patients With Advanced Triple-negative Breast Cancer
Condition: Triple-negative Breast Cancer Interventions: Drug: Apatinib; Drug: capecitabine Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Breast Cancer | Cancer | Cancer & Oncology | China Health | Hospitals | Research | Xeloda